ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel smartbeam(TM) laser ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
Watch this live virtual demo from Complete Phytochemical Solutions and Bruker labs to see the MALDI-TOF MS workflows for authenticity analysis of cranberry products. We will showcase several different ...
MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...
At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
(RTTNews) - Avacta Group plc (AVCT.L), a developer of Affimer biotherapeutics and reagents, announced Thursday that it has entered into a collaboration agreement with Bruker Corp. (BRKR) to evaluate ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
Bruker announced its new MALDI PharmaPulse 2.0 solution (MPP 2.0), which enhances the automation capabilities of the rapifleX MALDI-TOF mass spectrometer, with its proprietary scanning 10 kHz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results